Skip to NavigationSkip to content

News

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the UK has fallen to its lowest level in...
This week's top 10 stories on Pharmafile.com
Novartis has revealed that its disease modifying drug Gilenya (fingolimod) has secured approval in China for the treatment of relapsing forms of...
The Democratic Republic of Congo (DRC) has said it will stick with Merck’s rVSV-ZEBOV ebola vaccine, as it ruled out trialling other experimental...
The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks of Brexit.
The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” has been made in pushing for...
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment of adult...
Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States.
The UN health organisation has declared a global public health emergency over the Ebola outbreak, after an emergency committee meeting in Geneva.
The largest art gallery in the world has taken down all mentions of the Sackler family which include a plaque acknowledging their donations and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches